Monte Share Price

Monte Share Price

NASDAQ: GLUE | Small Cap | Healthcare
$9.09
+$0.04 (0.39%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Monte Stock Performance

Open
$9.23
Prev. Close
$9.05
Circuit Range
N/A
Day Range
$8.91 - $9.28
Year Range
$8.84 - $25.75
Volume
64,673
Average Traded
$9.15

Monte Share Price Today

As of 19 November 2026, Monte Rosa Therapeutics, Inc.'s share price is $9.09. The stock opened at $9.23, compared to its previous close of $9.05. During today's trading session, Monte Rosa Therapeutics, Inc.'s share price traded between $8.91 and $9.28, with an average price of $9.09. Over the past 52 weeks, the stock has recorded a high of $25.75 and a low of $8.84. In terms of performance, Monte Rosa Therapeutics, Inc.'s share price has declined by 53.88% over the last six months and is down 43.90% on a year-on-year basis.

Monte Share Price Chart

Line chart of the Monte price trend over the selected period. The price rose overall, ranging from 8.90 to 9.30, ending at 9.09.
$8.91$9.28
L
Show Current Price
H

Monte Stock Fundamentals & Key Indicators

Market Cap
$755.12M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.53
Revenue (TTM)
$123.67B
Return On Equity (TTM)
-26.39%
Profit Margin
-31.24%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
106.63%

Monte Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.78$4.21$8.97$54.37
Net Profit-$46.14-$44.50-$43.40$3.06
Net Profit Margin-1659.71%-1057.01%-483.84%5.63%
Income ChangeN/A3.55%2.47%107.05%

Monte Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$75.62$123.67
Net Profit-$108.50-$135.35-$72.70-$38.63
Net Profit MarginN/AN/A-96.14%-31.24%
Income ChangeN/A-24.75%46.29%46.86%

Monte Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets55.4761.2967.5466.5
Current Assets393.19377.44236.21275.89
Total Assets448.66438.73303.76342.39
Non Current Liabilities151.3958.8577.9145.41
Current Liabilities64.21156.9546.5925.57
Total Liabilities215.6215.8124.5170.98
Shareholders' Equity233.06222.94179.25271.41

Monte Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-22.842.0-43.8-92.47
Investing-101.83-44.4588.8-219.22
Financing30.3598.8927.4920.47

About Monte

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Monte Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$11.01
$9.10
-15.15%
Oct 2026
$12.04
$10.72
-10.10%
Sep 2026
$13.89
$11.93
-16.75%
Aug 2026
$16.73
$14.33
-13.31%
Jul 2026
$24.40
$16.53
-31.82%
Jun 2026
$19.73
$24.25
+23.01%
May 2026
$18.98
$19.71
+2.92%
Apr 2026
$16.89
$19.15
+16.48%
Mar 2026
$17.44
$16.44
-7.43%
Feb 2026
$20.65
$17.76
-13.47%
Jan 2026
$15.59
$20.52
+30.90%
Dec 2025
$15.91
$15.68
-3.23%

Monte Share Price FAQs